データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
日経平均は反落、クリスマス休暇入りで方向感に乏しい展開続く
2024's 'Biggest Loses' That Could See Reversal in 2025
Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Shares of Glucose Monitoring Stocks Are Trading Higher Following Weaker-than-expected Weight Loss Data From Novo Nordisk.
Intel Said to Consider Several Investment Firms, Lattice, for Altera Unit: Report